Psychedelics for Mental Health

Join the launch event on 3rd July with James Rucker, Robin Carhart-Harris and Rosalind Watts

To the UK Ministers for Drug Policy and Mental Health,

We call on you to reschedule the psychedelic substance psilocybin from Schedule 1 to Schedule 2.

4 million people suffer from depression & anxiety in the UK1. Research has shown the potential of psilocybin to treat these conditions2, 3, 4, 5, 6, yet it is being hindered by the restrictive Schedule 1 status of the substance.

The UK's drug scheduling system (Schedules 1-5) is separate from its classification system (Classes A-C)7. The Class of a drug affects the maximum penalty for an offence involving the drug, whilst the Schedule determines the regulations on its use in research and medicine.

Psilocybin is currently a Schedule 1 substance. Schedule 1 substances are not authorised for medical use and can only be supplied, possessed or administered in exceptional circumstances under a special Home Office licence. This means they cannot be prescribed by doctors, and that conducting research with them is extremely time-consuming and expensive.

By rescheduling psilocybin from Schedule 1 to Schedule 2, research would become faster and cheaper, and doctors would be able to start prescribing the substance when they see fit.

Out of compassion for those suffering from depression & anxiety, we ask that you take immediate action to reschedule psilocybin.

Sign

Supporting organisations

If your organisation supports this campaign, please let us know.





Reasons for signing

More reasons

Sign this petition

5,518 supporters

482 needed to reach 6,000

We'll send you occasional email updates on the activities of the Psychedelic Society.